Format
Sort by
Items per page

Send to

Choose Destination

Best matches for adherence; hypertension; persistence:

Search results

Items: 1 to 20 of 219

1.

Fixed Versus Free Combinations Of Antihypertensive Drugs: Analyses Of Real-World Data Of Persistence With Therapy In Italy.

Putignano D, Orlando V, Monetti VM, Piccinocchi G, Musazzi UM, Piccinocchi R, Minghetti P, Menditto E.

Patient Prefer Adherence. 2019 Nov 11;13:1961-1969. doi: 10.2147/PPA.S225444. eCollection 2019.

2.

PERson-centredness in hypertension management using information technology (PERHIT): a protocol for a randomised controlled trial in primary health care.

Midlöv P, Nilsson PM, Bengtsson U, Hoffmann M, Wennersten A, Andersson U, Malmqvist U, Steen Carlsson K, Ranerup A, Kjellgren K.

Blood Press. 2019 Dec 9:1-8. doi: 10.1080/08037051.2019.1697177. [Epub ahead of print]

PMID:
31814476
3.

Adherence to Treatment in Patients with Chronic Diseases: From Alertness to Persistence.

Danielson E, Melin-Johansson C, Modanloo M.

Int J Community Based Nurs Midwifery. 2019 Oct;7(4):248-257. doi: 10.30476/IJCBNM.2019.81303.0.

4.

A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial.

Pealing LM, Tucker KL, Mackillop LH, Crawford C, Wilson H, Nickless A, Temple E, Chappell LC, McManus RJ; OPTIMUM-BP Investigators.

Pregnancy Hypertens. 2019 Oct;18:141-149. doi: 10.1016/j.preghy.2019.09.018. Epub 2019 Oct 13.

PMID:
31618706
5.

Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.

Banerjee A, Benedetto V, Gichuru P, Burnell J, Antoniou S, Schilling RJ, Strain WD, Ryan R, Watkins C, Marshall T, Sutton CJ.

Heart. 2019 Oct 10. pii: heartjnl-2019-315307. doi: 10.1136/heartjnl-2019-315307. [Epub ahead of print]

6.

Effects of Community-Based Primary Care Management on Patients With Hypertension and Diabetes.

Kim HS, Suh Y, Kim MS, Yoo BN, Lee EJ, Lee EW, Park JH.

Asia Pac J Public Health. 2019 Sep;31(6):522-535. doi: 10.1177/1010539519867797. Epub 2019 Sep 15.

PMID:
31523988
7.

Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial.

Montalescot G, Brotons C, Cosyns B, Crijns HJ, D'Angelo A, Drouet L, Eberli F, Lane DA, Besse B, Chan A, Vicaut E, Darius H; AEGEAN Study Investigators.

Am J Cardiovasc Drugs. 2019 Jun 26. doi: 10.1007/s40256-019-00356-2. [Epub ahead of print]

PMID:
31243691
8.

Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients.

Qvarnström M, Kahan T, Kieler H, Brandt L, Hasselström J, Wettermark B.

Blood Press. 2019 Oct;28(5):309-316. doi: 10.1080/08037051.2019.1627858. Epub 2019 Jun 17.

PMID:
31203660
9.

[One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].

Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.

Orv Hetil. 2019 Mar;160(9):343-348. doi: 10.1556/650.2019.31355. Hungarian.

PMID:
30798621
10.

The association of angiotensin receptor blocker-based combination therapy with persistence and adherence in newly treated, uncomplicated hypertensive patients.

Ah YM, Shin J, Lee JY.

Patient Prefer Adherence. 2019 Jan 31;13:241-248. doi: 10.2147/PPA.S195423. eCollection 2019.

11.

Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study.

Zhou J, Han J, Nutescu EA, Patel PR, Sweiss K, Calip GS.

Pharmacotherapy. 2019 Jan;39(1):55-66. doi: 10.1002/phar.2197. Epub 2019 Jan 4.

PMID:
30485471
12.

Re-fracture and correlated risk factors in patients with osteoporotic vertebral fractures.

Ma X, Xia H, Wang J, Zhu X, Huang F, Lu L, He L.

J Bone Miner Metab. 2019 Jul;37(4):722-728. doi: 10.1007/s00774-018-0974-4. Epub 2018 Nov 21. Erratum in: J Bone Miner Metab. 2019 Apr 2;:.

PMID:
30465091
13.

Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database.

Studer S, Hull M, Pruett J, Koep E, Tsang Y, Drake W 3rd.

Pulm Circ. 2019 Jan-Mar;9(1):2045894018816294. doi: 10.1177/2045894018816294. Epub 2018 Nov 13.

14.

Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.

Ofori-Asenso R, Ilomäki J, Tacey M, Si S, Curtis AJ, Zomer E, Bell JS, Zoungas S, Liew D.

Br J Clin Pharmacol. 2019 Jan;85(1):227-235. doi: 10.1111/bcp.13797. Epub 2018 Nov 8.

PMID:
30402916
15.

Primary data, claims data, and linked data in observational research: the case of COPD in Germany.

Mueller S, Gottschalk F, Groth A, Meeraus W, Driessen M, Kohlmann T, Wilke T.

Respir Res. 2018 Aug 30;19(1):161. doi: 10.1186/s12931-018-0865-1.

16.

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis.

Kawalec P, Holko P, Gawin M, Pilc A.

Arch Med Sci. 2018 Aug;14(5):1125-1136. doi: 10.5114/aoms.2018.77561. Epub 2018 Aug 13. Review.

17.
18.

Adherence to and Persistence With Statin Therapy in a Veteran Population.

Morotti K, Lopez J, Vaupel V, Swislocki A, Siegel D.

Ann Pharmacother. 2019 Jan;53(1):43-49. doi: 10.1177/1060028018792702. Epub 2018 Aug 7.

PMID:
30084646
19.

Xafran, a drug utilization study of rivaroxaban in stroke prevention in atrial fibrillation in France using a claim database.

Dallongeville J, Sacher F, Bouée S, Emery C, Bureau I, Gourmelen J, Fauchier L.

Therapie. 2018 Dec;73(6):449-460. doi: 10.1016/j.therap.2018.06.003. Epub 2018 Jul 10.

PMID:
30075870
20.

Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study.

Warraich HJ, Kaltenbach LA, Fonarow GC, Peterson ED, Wang TY.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004528. doi: 10.1161/CIRCOUTCOMES.117.004528.

Supplemental Content

Loading ...
Support Center